Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 13
Submit an article Journal homepage
307
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluations

Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data

William Victor Bobo Vanderbilt University School of Medicine, Department of Psychiatry, 1500 21st Ave South, Village at Vanderbilt, Nashville, TN 37212, USA [email protected]
&
Richard C Shelton Vanderbilt University School of Medicine, Department of Psychiatry, 1500 21st Ave South, Village at Vanderbilt, Nashville, TN 37212, USA [email protected]
Pages 2145-2159 | Published online: 29 Jul 2009

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

William V Bobo. (2013) Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Expert Review of Clinical Pharmacology 6:1, pages 61-91.
Read now
Noah S Philip, Linda L Carpenter, Audrey R Tyrka & Lawrence H Price. (2010) Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opinion on Pharmacotherapy 11:5, pages 709-722.
Read now

Articles from other publishers (15)

Naji C. Salloum, Maurizio Fava, Sophia Ball & George I. Papakostas. (2020) Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review. Molecular Psychiatry 25:9, pages 1967-1974.
Crossref
Xiao-Ming Si, Yu-Hua Tian, Sha-Sha Zhang, Hua Gao, Kun Liu & Jing-Yu Jin. (2018) Low molecular mass chondroitin sulfate suppresses chronic unpredictable mild stress-induced depression-like behavior in mice. Acta Pharmaceutica 68:3, pages 361-371.
Crossref
Reef Einoch, Orly Weinreb, Nina Mandiuk, Moussa B.H. Youdim, Warren Bilker & Henry Silver. (2017) The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia. European Neuropsychopharmacology 27:5, pages 470-483.
Crossref
A. L. D’yakonov & I. V. Lobanova. (2014) Comparative Studies of the Efficacy of Combinations of SSRI Antidepressants and Antipsychotics in the Treatment of Recurrent Depressive Disorder. Neuroscience and Behavioral Physiology 44:2, pages 195-199.
Crossref
Thalia K. Robakis & Katherine Ellie Williams. (2013) Biologically based treatment approaches to the patient with resistant perinatal depression. Archives of Women's Mental Health 16:5, pages 343-351.
Crossref
Marek Krzystanek, Ewa Krzystanek, Henryk I. Trzeciak, Andrzej Małecki, Irena Krupka-Matuszczyk, Małgorzata Janas-Kozik & Janusz K. Rybakowski. (2013) Effects of olanzapine and paroxetine on phospholipase D activity in the rat brain. Pharmacological Reports 65:3, pages 724-729.
Crossref
Lena Danovich, Orly Weinreb, Moussa B. H. Youdim & Henry Silver. (2011) Chronic treatment with serotonin reuptake inhibitor antidepressant (SSRI) combined with an antipsychotic regulates GABA-A receptor in rat prefrontal cortex. Psychopharmacology 220:4, pages 763-770.
Crossref
Neil M. Fournier & Ronald S. Duman. (2012) Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depression. Behavioural Brain Research 227:2, pages 440-449.
Crossref
Henry Silver, Ehud Susser, Lena Danovich, Warren Bilker, Moussa Youdim, Vladimir Goldin & Orly Weinreb. (2010) SSRI augmentation of antipsychotic alters expression of GABAA receptor and related genes in PMC of schizophrenia patients. The International Journal of Neuropsychopharmacology 14:05, pages 573-584.
Crossref
Lena Danovich, Orly Weinreb, Moussa B. H. Youdim & Henry Silver. (2010) The involvement of GABAA receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment. The International Journal of Neuropsychopharmacology 14:02, pages 143-155.
Crossref
. (2011) Current World Literature. Current Opinion in Psychiatry 24:1, pages 78-87.
Crossref
Denis Boulay, Ronan Depoortere, Caroline Louis, Martine Lacave, Marie Thérèse Lucas & Guy Griebel. (2011) SSR181507, a dopamine D2 receptor and 5-HT1A receptor ligand: Evidence for mixed anxiolytic- and antidepressant-like activities. Pharmacology Biochemistry and Behavior 97:3, pages 428-435.
Crossref
Jamie D. Croxtall & Lesley J. Scott. (2010) Olanzapine/Fluoxetine. CNS Drugs 24:3, pages 245-262.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:3, pages i-xiii.
Crossref
William V. BoboRichard A. EpsteinJr.Jr. & Richard C. Shelton. (2010) Acute Bipolar Depression: A Review of the Use of Olanzapine/Fluoxetine. Clinical Medicine Insights: Therapeutics 2, pages CMT.S1945.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.